| Activity of platinum-based chemotherapy in patients with advanced prostate cancer with and without DNA repair gene aberrations S Schmid, A Omlin, C Higano, C Sweeney, NM Chanza, N Mehra, ... JAMA network open 3 (10), e2021692-e2021692, 2020 | 84 | 2020 |
| Immune-mediated pericarditis with pericardial tamponade during nivolumab therapy DVP De Almeida, JR Gomes, FJ Haddad, AC Buzaid Journal of Immunotherapy 41 (7), 329-331, 2018 | 51 | 2018 |
| Risk of fatigue and anemia in patients with advanced cancer treated with olaparib: a meta-analysis of randomized controlled trials VC Ruiz-Schutz, LM Gomes, RC Mariano, DVP de Almeida, JM Pimenta, ... Critical reviews in oncology/hematology 141, 163-173, 2019 | 45 | 2019 |
| Immune checkpoint blockade for prostate cancer: niche role or next breakthrough? DVP de Almeida, L Fong, MB Rettig, KA Autio American Society of clinical oncology educational book 40, e89-e106, 2020 | 32 | 2020 |
| Efeitos cardiovasculares da cafeína: revisão de literatura DVP Almeida, NK Pereira, DAR Moreira Rev. Ciên. Saúde 3, 2, 2013 | 10* | 2013 |
| Platinum-based therapy in men with metastatic castration resistant prostate (mCRPC) with or without DNA repair defects: A multicentre retrospective analysis S Gillessen, S Schmid, H Beltran, DVP Almeida, N Mehra, P Lavaud, ... Annals of Oncology 29, viii282, 2018 | 4 | 2018 |
| Non-metastatic castration-resistant prostate cancer (nmCRPC): meta-analysis of efficacy and safety with novel hormonal agents apalutamide and enzalutamide DVP Almeida, CZ de Oliveira, RC Mariano, FR Kater, M Souza, ... Annals of Oncology 29, viii279, 2018 | 3 | 2018 |
| Meta-analysis of randomized clinical trials (RCT) for the adjuvant treatment of renal cell carcinoma (RCC) with vascular endothelial growth factor receptor tyrosine-kinase … DV Almeida, CZ Oliveira, A Soares, RC Mariano, DL Jardim, DA Bastos, ... Journal of Clinical Oncology 37 (15_suppl), 4579-4579, 2019 | 1 | 2019 |
| Impact of multidisciplinary discussion on therapeutic decision in cancer patients: a prospective observational study. CP Amaro, L Gomes, D Almeida, K Reiner, GFG Almeida, MRS Cruz Journal of Clinical Oncology 35 (15_suppl), e18243-e18243, 2017 | 1 | 2017 |
| Real world data of leuprorelin castration efficacy in patients with prostate cancer: A comprehensive assessment of 1,744 tests. DPS Lages, GA Zulli, PG Bergerot, M Barbosa, FM Carcano, L Lages, ... Journal of Clinical Oncology 42 (16_suppl), e17000-e17000, 2024 | | 2024 |
| Effect of a 12-week remote exercising program (ExIOnc) on quality of life and symptoms of older patients with cancer in Brazil. PG Bergerot, CD Bergerot, JRG Silva, MVS Franca, DPS Lages, ... Journal of Clinical Oncology 42 (16_suppl), 1623-1623, 2024 | | 2024 |
| Can PSMA-PET be a better way to select patients for an intermittent treatment? Results from a prospective cohort. DPS Lages, GA Zulli, FM Carcano, M Barbosa, L Lages, PG Bergerot, ... Journal of Clinical Oncology 42 (16_suppl), e17073-e17073, 2024 | | 2024 |
| Impact of combined novel hormonal agents on testosterone levels of patients with prostate cancer undergoing treatment with leuprorelin. DPS Lages, D Vargas Pivato de Almeida, PG Bergerot, M Barbosa, ... Journal of Clinical Oncology 42 (4_suppl), 95-95, 2024 | | 2024 |
| Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer DVP de Almeida, JM Anderson, DC Danila, MJ Morris, SF Slovin, W Abida, ... Journal of Immunotherapy and Precision Oncology 6 (4), 162-169, 2023 | | 2023 |
| A supervised remote exercising program for patients receiving immunotherapy alone or in combination with chemotherapy in Brazil: ExIO. PG Bergerot, CD Bergerot, JRG Silva, MA Paes, J Farias, DPS Lages, ... Journal of Clinical Oncology 41 (16_suppl), 12122-12122, 2023 | | 2023 |
| Patterns of recurrence post prostatectomy in the PSMA era: What lessons can we take to daily practice from a high-volume nuclear medicine center? DPS Lages, L Monteiro do Prado Junior, L Fonseca Monteiro do Prado, ... Journal of Clinical Oncology 41 (16_suppl), e17013-e17013, 2023 | | 2023 |
| Nutritional program among patients with prostate cancer receiving androgen deprivation therapy (ADT). DPS Lages, D Vargas Pivato de Almeida, CD Bergerot, PG Bergerot, ... Journal of Clinical Oncology 41 (16_suppl), 12072-12072, 2023 | | 2023 |
| Non-metastatic, Castration-resistant Prostate Cancer: Diagnostic and Treatment Recommendations by an Expert Panel from Brazil DL Jardim, AG e Silva, ASFL Pompeo, AS Sarkis, APG Cardoso, ... Clinical Genitourinary Cancer 21 (2), e58-e69, 2023 | | 2023 |
| Comparative analysis of contemporary and past PSMA PET/CT results for recurrent prostate cancer in a high-volume Brazilian center. DPS Lages, L Monteiro do Prado Junior, L Fonseca Monteiro do Prado, ... Journal of Clinical Oncology 41 (6_suppl), 51-51, 2023 | | 2023 |
| Updated experience on PSMA PET/CT for recurrent prostate cancer in a high-volume Brazilian center. DPS Lages, L Monteiro do Prado Junior, L Fonseca Monteiro do Prado, ... Journal of Clinical Oncology 41 (6_suppl), 50-50, 2023 | | 2023 |
